San Francisco Marriott Marquis

Dyadic to Attend Future Food Tech Event March 21 – 22, 2024 in San Francisco, California

Retrieved on: 
Thursday, March 21, 2024
Transferrin, Biotechnology, Partnership, Business development, Dyadic, Food, San Francisco Marriott Marquis, Medium (website), Future, Vaccine

Dyadic will be showcasing its Dapibus™ Microbial Expression System and providing updates on the progress of current products under development within its alternative proteins business unit.

Key Points: 
  • Dyadic will be showcasing its Dapibus™ Microbial Expression System and providing updates on the progress of current products under development within its alternative proteins business unit.
  • We believe this system holds promise for revolutionizing protein expression and production in various industries, including food, nutrition, and healthcare.
  • Moreover, Dyadic has recently entered into a co-marketing partnership with Biftek, Inc. (“Biftek”).
  • If you would like to schedule a meeting with our management members at Future Food Tech in San Francisco, please contact Heidi Zosiak at [email protected] or stop by the Dyadic International, Inc. booth (#20).

Alkeus Pharmaceuticals to Present at the 42nd Annual J.P. Morgan Healthcare Conference on Jan. 10, 2024

Retrieved on: 
Thursday, December 21, 2023
PST, Conference, San Francisco Marriott Marquis, Paratriathlon

CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Joshua Boger, Ph.D., Executive Chairman, and Leonide Saad, Ph.D., President and Chief Executive Officer, will provide a corporate update and present the latest information on its late-stage investigational therapy to prevent blindness, during the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 10, 2024, at 11:30 a.m. PST at The Westin St. Francis Hotel.

Key Points: 
  • CAMBRIDGE, Mass., Dec. 21, 2023 (GLOBE NEWSWIRE) -- Alkeus Pharmaceuticals, Inc. today announced that Joshua Boger, Ph.D., Executive Chairman, and Leonide Saad, Ph.D., President and Chief Executive Officer, will provide a corporate update and present the latest information on its late-stage investigational therapy to prevent blindness, during the 42nd Annual J.P. Morgan Healthcare Conference in San Francisco on Wednesday, Jan. 10, 2024, at 11:30 a.m. PST at The Westin St. Francis Hotel.
  • There will be no live webcast of the presentation.
  • In addition, Dr. Boger will participate in a panel discussion during Endpoints at #JPM24 on Tuesday, Jan. 9, 2024, at 9:40 a.m. – 10:10 a.m. PST at the San Francisco Marriott Marquis, titled “Biotech Downturn Survival School.”

China Strategic Risk Institute (CSRI), Free World Investment (FWI) and Visual Artists Guild (VAG) Announce the Parallel APEC CEO Conference 2023 – Assessing Business Risks in China & Hong Kong (ABC-HK)

Retrieved on: 
Monday, November 6, 2023
Finance, Consulting, Professional Services, Public Policy, Government, Other Policy Issues, Fraser Institute, International Chinese Language Program, FWI, Investment, Democracy, CIPE, San Francisco Marriott Marquis, Private sector, APEC, Imperial College London, Business risks, Pacific Ocean, Management

In the midst of heightened geopolitical tensions and shifting economic landscapes in China and Hong Kong, the ABC-HK - Assessing Business Risks in China and Hong Kong conference is set to take place on November 15, 2023, at the San Francisco Marriott Marquis.

Key Points: 
  • In the midst of heightened geopolitical tensions and shifting economic landscapes in China and Hong Kong, the ABC-HK - Assessing Business Risks in China and Hong Kong conference is set to take place on November 15, 2023, at the San Francisco Marriott Marquis.
  • This crucial forum will be held within the same security zone of APEC CEO Summit 2023, providing a platform for business leaders to analyze the changing business dynamics and re-evaluate their investment strategies in China and Hong Kong.
  • Co-hosted by Free World Investment (FWI) and the China Strategic Risks Institute (CSRI), the ABC-HK conference will explore the escalating investment and geopolitical risks that the business community is facing in China and Hong Kong following the implementation of the National Security Law.
  • These experts will guide attendees through the changing business landscapes, offering insights for navigating China and Hong Kong’s complex investment terrain amid shifting global politics and domestic policies.

RG6501 (OpRegen®) Phase 1/2a Results to Be Featured at Eyecelerator at 2023 American Academy of Ophthalmology (AAO) Annual Meeting

Retrieved on: 
Tuesday, October 24, 2023
Health, Clinical Trials, Research, Science, Pharmaceutical, Optical, Biotechnology, Janus, Medical Affairs Bureau, Lineage Cell Therapeutics, AMD, AAO, Cell, Geographic atrophy, OD, RPE, Division, San Francisco Marriott Marquis, American Academy, GA, American Academy of Ophthalmology, Lineage, Annual general meeting, Macular degeneration, Roche, TASE, CFA, NYSE American, San Francisco, Therapy, Patient, Food and Drug Administration, Pharmaceutical industry, Ophthalmology, Genentech

In addition, the results of imaging analyses demonstrating evidence of rapid improvement in outer retinal structure and continued clinical benefit in subjects from a Phase 1/2a clinical study of RG6501 ( OpRegen ) (ClinicalTrials.gov Identifier: NCT02286089 ), have been accepted for presentation at Eyecelerator 2023 .

Key Points: 
  • In addition, the results of imaging analyses demonstrating evidence of rapid improvement in outer retinal structure and continued clinical benefit in subjects from a Phase 1/2a clinical study of RG6501 ( OpRegen ) (ClinicalTrials.gov Identifier: NCT02286089 ), have been accepted for presentation at Eyecelerator 2023 .
  • Eyecelerator will occur prior to the American Academy of Ophthalmology (AAO) 2023 Annual Meeting and will be held at the San Francisco Marriott Marquis on Thursday, November 2nd, 2023.
  • RG6501 (OpRegen) is a suspension of human allogeneic retinal pigmented epithelial (RPE) cells currently in development for the treatment of GA secondary to age-related macular degeneration (AMD).
  • OpRegen subretinal delivery has the potential to counteract RPE cell loss in areas of GA lesions by supporting retinal cell health and improving retinal structure and function.

Fortanix Launches Industry-First Confidential Data Search for Regulated Encrypted Data

Retrieved on: 
Tuesday, June 27, 2023
Security, IOT (Internet of Things), Other Technology, Telecommunications, Networks, Internet, Hardware, Electronic Commerce, Professional Services, Data Management, Online Privacy, Technology, Mobile, Wireless, Fintech, Data Analytics, Payments, Health, Apps, Applications, Health Technology, DevOps, Database, FINMA, PQC, DSM, Software as a service, SECS/GEM, SQL, Association of European Operational Research Societies, FIPS 140-2, Public, COVID-19, Health equity, HE, Record, San Francisco Marriott Marquis, Blog, Privacy, Confidentiality, Organization, Next, Byte, GDPR, Growth, PCI-DSS, Environment, HIPAA, Cryptocurrency, Pharmaceutical industry, Computer data storage

SANTA CLARA, Calif., June 27, 2023 — Fortanix® Inc. , the innovative multi-cloud data security company and the pioneer of Confidential Computing, today announced the release of Fortanix Confidential Data Search , an industry-first, high-performance solution that supports highly scalable searches in encrypted databases with sensitive data, without compromising data security or privacy regulations.

Key Points: 
  • SANTA CLARA, Calif., June 27, 2023 — Fortanix® Inc. , the innovative multi-cloud data security company and the pioneer of Confidential Computing, today announced the release of Fortanix Confidential Data Search , an industry-first, high-performance solution that supports highly scalable searches in encrypted databases with sensitive data, without compromising data security or privacy regulations.
  • Available now as a private preview, the fully featured general availability of Fortanix Confidential Data Search is targeted to roll out in the second half of 2023.
  • Fortanix's new Confidential Data Search solution addresses data security requirements while maintaining full support for streamlined business operations.
  • Fortanix Confidential Data Search provides confidentiality for the query issuer and the data owner, and any arbitrary SQL query can be performed without a loss of fidelity or prohibitive system latency.

Fivetran Hosts Third Annual Modern Data Stack Conference in San Francisco on April 4-5 2023

Retrieved on: 
Wednesday, March 15, 2023
Networks, Data Analytics, Internet, Data Management, Professional Services, Technology, Logistics, Supply Chain Management, Transport, Conference, Learning, Fantasy, Supply, Barack Obama, JetBlue, DocuSign, San Francisco Marriott Marquis, DJ Patil, Organization, Cisco, Databricks, Sigma, Snowflake, Federation, AutoZone, Video game, Management, Coalesce, Autodesk

Fivetran , the global leader in automated data movement, announced today that the third annual Modern Data Stack Conference will be held April 4-5, 2023 at the San Francisco Marriott Marquis.

Key Points: 
  • Fivetran , the global leader in automated data movement, announced today that the third annual Modern Data Stack Conference will be held April 4-5, 2023 at the San Francisco Marriott Marquis.
  • This year, the Modern Data Stack Conference expands to an in-person event that will convene hundreds of data analysts, data engineers and experienced data professionals for a mixture of informative sessions, hands-on learning and networking opportunities.
  • “We’ve been very pleased with the success of our previous virtual Modern Data Stack conferences.
  • It’s a perfect forum to learn first-hand about data industry innovations and best practices that enterprises are deploying to make data-driven decisions.”
    Knitting Your Own Data Fabric: Real Possibility or Impossible Fantasy
    The Future of the Supply Chain: How the Modern Data Stack is Transforming Logistics
    Sponsors of the 2023 Modern Data Stack Conference include: Databricks, Snowflake, dbt Labs, Alation, Coalesce, Hightouch, Monte Carlo, Sigma and more.

INVECTYS, INC. TO PARTICIPATE IN THE 41st JP MORGAN HEALTHCARE CONFERENCE ON JANUARY 9-12, 2023

Retrieved on: 
Thursday, January 5, 2023
Cancer, Patient, BIO, San Francisco Marriott Marquis, Pharmaceutical industry, Inspection, Medical device

Houston, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc. “Invectys”, a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of cell therapy products for cancer patients, today announced that Praveen Tyle, Ph.D., President and CEO of Invectys, will participate in the 2023 edition of the JP Morgan Healthcare Meeting on January 9-12, 2023.

Key Points: 
  • Houston, Texas, Jan. 05, 2023 (GLOBE NEWSWIRE) -- Invectys, Inc. “Invectys”, a clinical-stage immunotherapy company headquartered in Houston and dedicated to the development of a new generation of cell therapy products for cancer patients, today announced that Praveen Tyle, Ph.D., President and CEO of Invectys, will participate in the 2023 edition of the JP Morgan Healthcare Meeting on January 9-12, 2023.
  • In addition to the main meeting, Dr. Tyle will also attend the 2023 BIO One-on-One partnering meetings live from January 9-12 at the San Francisco Marriott Marquis.
  • If you would like to set up a meeting, feel free to contact us at [email protected] .

Sabra Health Care REIT, Inc. to Attend Nareit’s REITworld 2022 Annual Conference

Retrieved on: 
Tuesday, November 1, 2022
REIT, Other Construction & Property, Residential Building & Real Estate, Commercial Building & Real Estate, Construction & Property, San Francisco Marriott Marquis, Conference, Senior, Trust, Finance

Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the companys Chair and Chief Executive Officer, Michael Costa, the companys Chief Financial Officer, Talya Nevo-Hacohen, the companys Chief Investment Officer, and Lukas Hartwich, the companys Senior Vice President of Finance, will attend Nareits REITworld 2022 Annual Conference November 15-17, 2022, at the San Francisco Marriott Marquis in San Francisco, California.

Key Points: 
  • Sabra Health Care REIT, Inc. (Nasdaq: SBRA) announced today that Rick Matros, the companys Chair and Chief Executive Officer, Michael Costa, the companys Chief Financial Officer, Talya Nevo-Hacohen, the companys Chief Investment Officer, and Lukas Hartwich, the companys Senior Vice President of Finance, will attend Nareits REITworld 2022 Annual Conference November 15-17, 2022, at the San Francisco Marriott Marquis in San Francisco, California.
  • Sabra Health Care REIT, Inc., a Maryland corporation, operates as a self-administered, self-managed real estate investment trust (a "REIT") that, through its subsidiaries, owns and invests in real estate serving the healthcare industry throughout the United States and Canada.
  • View source version on businesswire.com: https://www.businesswire.com/news/home/20221101005293/en/

Si2 Names Recipients of Annual Power of Partnerships Award

Retrieved on: 
Wednesday, June 29, 2022
Software, Mobile, Wireless, Internet, Hardware, Electronic Design Automation, Data Management, Consumer Electronics, Technology, Semiconductor, Security, Nanotechnology, Other Technology, Telecommunications, Coalition, Design Automation Conference, Compact Model Coalition, Research, National Cooperative Research and Production Act, Silicon, San Francisco Marriott Marquis, OA, Global Smoke-Free Partnership Award, Silicon Integration Initiative, IC, Defense Production Act of 1950, Si2, OpenAccess, Intel, Cadence Design Systems, IBM, EDA, Database, Microsoft, Conference, Video game, Mobile phone

Technologists from Intel, IBM, Microsoft and Cadence Design Systems are this year's Silicon Integration Initiative Power of Partnerships Award winners, recognizing the Si2 volunteer team with the most significant contributions to silicon-to-system implementation.

Key Points: 
  • Technologists from Intel, IBM, Microsoft and Cadence Design Systems are this year's Silicon Integration Initiative Power of Partnerships Award winners, recognizing the Si2 volunteer team with the most significant contributions to silicon-to-system implementation.
  • The OA database creates interoperability between EDA companies and semiconductor designers and manufacturers.
  • The Si2 board of directors is focused on improving OA interoperability and this team has risen to the challenge," said Marshall Tiner, senior director of OA.
  • The Si2 membership includes more than 65 semiconductor and fabless manufacturers, foundries and EDA companies.

Si2 Forum Addresses Novel Approaches to Low-Power Semiconductor Design

Retrieved on: 
Monday, June 20, 2022
Semiconductor, Electronic Design Automation, Technology, Artificial Intelligence, Software, Solution, Industry, Design Automation Conference, Marriott Marquis, Technology, Semiconductor, Efficiency, Silicon, Adoption, Research, EDA, Si2, Silicon Integration Initiative, National Cooperative Research and Production Act, Automation, Defense Production Act of 1950, AI, Admission, IEEE, Conference, IEEE CEDA, San Francisco Marriott Marquis, Goal, Consumer electronics, Communications satellite, Mobile phone

Cosponsored by IEEE CEDA, the Si2 Low-Power Forum features ten leading semiconductor design architects, academics, and practitioners of electronic design automation.

Key Points: 
  • Cosponsored by IEEE CEDA, the Si2 Low-Power Forum features ten leading semiconductor design architects, academics, and practitioners of electronic design automation.
  • They will present novel strategies and solutions for speeding the adoption of low-power design, and fabrication of semiconductors.
  • Advanced system design architectures are limited by efficiency and scalability of low-power analysis, said Leigh Anne Clevenger, Si2 vice president, technology.
  • The Si2 membership includes more than 65 semiconductor and fabless manufacturers, foundries and EDA companies.